Are European-Specific Guidelines Needed for Prevention of Opportunistic Infections in HIV-1?

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Are European-Specific Guidelines Needed for Prevention of Opportunistic Infections in HIV-1?

Lancet (10/09/99) Vol. 354, No. 9186, P. 1305
Yazdanpanah, Yazdan; Goldie, Sue J.; Salamon, Roger; et al.

A letter to the editor of the Lancet discusses the need for European-specific guidelines for the prevention of opportunistic infections in HIV-1-infected patients. Researchers surveyed 49 coordinators of AIDS surveillance in the World Health Organization European region. Of the 30 coordinators who responded, 14 percent supplied their own nation-specific guidelines, including recommendations similar to those from the U.S. Public Health Service and the Infectious Disease Society of America (USPHS/IDSA) with key exceptions. However, 25 coordinators said their countries had no national guidelines, with 16 saying they followed the USPHS/IDSA recommendations and two reporting that they used guidelines established by specialized HIV/AIDS units in university centers. The authors note that U.S. guidelines may not be directly transferable to patients in Europe, since practice settings and patient populations may be different. Local data on opportunistic infections can be put into decision analytical models to estimate the efficacy and cost- effectiveness of site-specific recommendations, the researchers said.

991015
AD991746

Copyright © 1999 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.